The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes

Detalles Bibliográficos
Autores principales:	Mohanlal, N, Holman, R
Formato:	Conference item
Publicado:	2002

Ejemplares similares

Nateglinide, but not repaglinide, stimulates growth hormone secretion from rat pituitary cells.
por: Bokvist, K, et al.
Publicado: (2000)

Effect of nateglinide on the incidence of diabetes and cardiovascular events.
por: Holman, R, et al.
Publicado: (2010)

A review of nateglinide in the management of patients with type 2 diabetes
por: Nicholas Tentolouris, et al.
Publicado: (2008-01-01)

Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
por: Gribble, F, et al.
Publicado: (2001)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
por: Califf, R, et al.
Publicado: (2008)

Helical‐Like Assembly of Nateglinide as Coating for Oral Delivery of Insulin and Their Synergistic Prevention of Diabetes Mellitus
por: Yanfei Li, et al.
Publicado: (2023-10-01)

Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
por: Leilei Wang, et al.
Publicado: (2013-01-01)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
por: Marc K Israel, et al.
Publicado: (2008-12-01)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
por: Krum, H, et al.
Publicado: (2010)

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
por: Latini, R, et al.
Publicado: (2013)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
por: Preiss, D, et al.
Publicado: (2013)

Drosophila adiponectin receptor in insulin producing cells regulates glucose and lipid metabolism by controlling insulin secretion.
por: Su-Jin Kwak, et al.
Publicado: (2013-01-01)

The effect of glibenclamide on insulin secretion at normal glucose concentrations
por: Riefflin, A, et al.
Publicado: (2014)

The effect of glibenclamide on insulin secretion at normal glucose concentrations.
por: Riefflin, A, et al.
Publicado: (2015)

Altered postprandial responses in type 2 diabetes
por: Mohanlal, N, et al.
Publicado: (2001)

Heterogenous glucose-stimulated insulin secretion at single islet level
por: Jiaxiang Yin, et al.
Publicado: (2023-12-01)

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.
por: Mark K Nøhr, et al.
Publicado: (2016-01-01)

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
por: Kato Toru, et al.
Publicado: (2010-03-01)

Deletion of protein kinase C epsilon in mice enhances glucose stimulated insulin secretion following lipid exposure by up-regulation of the amplifying pathways of insulin secretion
por: Cantley, J, et al.
Publicado: (2008)

Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets
por: Yi Cheng, et al.
Publicado: (2023-11-01)

Correction: Geniposide Regulates Glucose-Stimulated Insulin Secretion Possibly through Controlling Glucose Metabolism in INS-1 Cells
Publicado: (2014-01-01)

Correction: Geniposide Regulates Glucose-Stimulated Insulin Secretion Possibly through Controlling Glucose Metabolism in INS-1 Cells.
por: Jianhui Liu, et al.
Publicado: (2014-01-01)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
por: Preiss, D, et al.
Publicado: (2012)

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
por: Mcmurray, J, et al.
Publicado: (2011)

Pseudoislet Aggregation of Pancreatic β-Cells Improves Glucose Stimulated Insulin Secretion by Altering Glucose Metabolism and Increasing ATP Production
por: Deborah Cornell, et al.
Publicado: (2022-07-01)

Modification of postprandial lipid profiles in people with diabetes
por: Mohanlal, N, et al.
Publicado: (2003)

Effect of Human Myotubes-Derived Media on Glucose-Stimulated Insulin Secretion
por: Maria L. Mizgier, et al.
Publicado: (2017-01-01)

An ancestral role for the mitochondrial pyruvate carrier in glucose-stimulated insulin secretion
por: Kyle S. McCommis, et al.
Publicado: (2016-08-01)

Hypothalamic AMP-activated Kinase Regulates Glucose-stimulated Insulin Secretion
por: Eun Hee Koh, et al.
Publicado: (2016-11-01)

ARHGAP21 Acts as an Inhibitor of the Glucose-Stimulated Insulin Secretion Process
por: Sandra M. Ferreira, et al.
Publicado: (2020-11-01)

Low extracellular magnesium does not impair glucose-stimulated insulin secretion.
por: Lisanne M M Gommers, et al.
Publicado: (2019-01-01)

Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes.
por: Hosker, J, et al.
Publicado: (1988)

Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion
por: Hovsepyan Meri, et al.
Publicado: (2009-07-01)

Correction to: Standardized extract of Ficus deltoidea stimulates insulin secretion and blocks hepatic glucose production by regulating the expression of glucose-metabolic genes in streptozitocin-induced diabetic rats
por: Elham Farsi, et al.
Publicado: (2018-09-01)

Insulin rather than glucose homoeostasis in the pathophysiology of diabetes.
por: Turner, R, et al.
Publicado: (1976)

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma
por: Nihar Ranjan Pani, et al.
Publicado: (2012-12-01)

A pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell
por: M. Deepa Maheshvare, et al.
Publicado: (2023-08-01)

Effects of subtotal pancreatectomy and long‐term glucose and lipid overload on insulin secretion and glucose homeostasis in minipigs
por: Rébecca Goutchtat, et al.
Publicado: (2023-07-01)

Biphasic nature of glucose-induced insulin secretion is independent on energy metabolism
por: Tarasov, A, et al.
Publicado: (2014)

New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
por: Ivan Ivanovich Dedov, et al.
Publicado: (2015-10-01)